Oceanía · Mercados regionales · Stockhead

TrivarX takes key step towards trial of next-gen cancer imaging technology

Publicado por Stockhead · Australia hace 1 h

Syntro Health will undertake laboratory formulation activities for the Stabl-Im investigational product, with TrivarX (ASX:TRI) targeting first patient enrolment in ... Read More…

Leer el artículo completo en Stockhead Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (stockhead.com.au)

TrivarX takes key step towards trial of next-gen cancer imaging technology

También te puede interesar

3 buy-rated ASX growth shares with big international ambitions

The West confronts the reality of unconditional tolerance

Gingerah's 1GW data centre, 6.7GW renewables project joins EPBC queue

Pumped hydro project scrapped after developer deems it unviable

Australian businesses pull websites offline over PHP threat

Victoria’s government-backed Alice Anderson Fund for women founders scores another $10 million

TrivarX takes key step towards trial of next-gen cancer imaging technology

Compartir

También te puede interesar

3 buy-rated ASX growth shares with big international ambitions

The West confronts the reality of unconditional tolerance

Gingerah's 1GW data centre, 6.7GW renewables project joins EPBC queue

Pumped hydro project scrapped after developer deems it unviable

Australian businesses pull websites offline over PHP threat

Victoria’s government-backed Alice Anderson Fund for women founders scores another $10 million